Portfolio

PregnanTech

Game-changing device for the prevention of preterm birth

Technology Development

Business Development

Revenue

Exited

Founded

2018

CEO
David Shashar, MD
UN SDGs
3
10
Contact Us
email email
Follow Us
linkedin
Investors
The Trendlines Group, Sheba Medical Center, Israel Innovation Authority, private investors

About

PregnanTech is developing Lioness, a small, game-changing device to prevent preterm birth.

Lioness is a disposable silicone device placed in the vagina and secured high around the uterine cervix. Lioness maintains its position on the cervix despite pressure and contractions, stopping cervical dilatation, keeping the cervix elongated, and delaying the “cascade” that leads to preterm birth.

Market Need

Preterm birth is the #1 problem in obstetrics. Between 9% and 17% of all pregnant women are at risk for preterm birth. In the United States, expenses associated with preterm births surpass $25 billion annually. Unfortunately, existing solutions for prevention and delay of spontaneous preterm birth do not provide effective results. This is why the rate of preterm births worldwide has not changed for decades. There is a critical need for an effective solution that will delay or prevent preterm birth, improve newborn health and reduce costs.

Skip to content